The company is developing a brain implant that aims to help patients with severe paralysis control external technologies using only neural signals. The in-human clinical trial marks just one step on Neuralink's path toward commercialization. Neuralink did not disclose how many human patients will participate in its initial in-human trial. Paradromics is aiming to launch its first trial with human patients in the first half of this year. Precision Neuroscience carried out its first in-human clinical study last year.

---

Persons: Elon, Neuralink, Musk, Stephen Hawking, Blackrock Neurotech, Tom Oxley's Organizations: U.S . Food, Drug Administration, FDA, SpaceX, BCI, Neuroscience, Paradromics, Blackrock Locations: U.S